The International Scientific Forum on Alcohol Research (ISFAR) critiques of alcohol research: Promoting health benefits and downplaying harms.

IF 5.3 1区 医学 Q1 PSYCHIATRY
Addiction Pub Date : 2025-07-09 DOI:10.1111/add.70132
James M Clay, Tim Stockwell, Su Golder, Keegan Lawrence, Jim McCambridge, Nicole Vishnevsky, Alexandra Zuckermann, Timothy Naimi
{"title":"The International Scientific Forum on Alcohol Research (ISFAR) critiques of alcohol research: Promoting health benefits and downplaying harms.","authors":"James M Clay, Tim Stockwell, Su Golder, Keegan Lawrence, Jim McCambridge, Nicole Vishnevsky, Alexandra Zuckermann, Timothy Naimi","doi":"10.1111/add.70132","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>The International Scientific Forum on Alcohol Research (ISFAR), many of whose members are linked to the alcohol industry, has published over 280 critiques on alcohol and health research. This study investigated whether ISFAR critiques favour studies reporting alcohol's health benefits while being more critical of those identifying harms. We also examined whether industry-funded studies are more likely to report benefits, and whether ISFAR's critiques reflect the methodological rigor of the studies they assess.</p><p><strong>Methods: </strong>We analysed 268 ISFAR critiques published between April 2010 and January 2024, manually coding each underlying study for its content (whether the original study reported alcohol-related health benefits or harms) and each critique for its tone (positive or negative). Sentiment analysis (SA) algorithms were applied to critique summaries to assess tone using automated methods. Study authors were examined for prior receipt of alcohol industry funding. AMSTAR-2 and ROBIS tools evaluated risk of bias in 36 systematic reviews and meta-analyses favoured (n = 24) or criticised (n = 12) by ISFAR.</p><p><strong>Results: </strong>Studies reporting health benefits had higher odds of receiving positive reviews from ISFAR [odds ratio (OR) = 6.50, 95% confidence interval (95% CI) = (3.62-12.00)], as did studies minimising alcohol harms [OR = 2.47, 95% CI = (1.40-4.45)]. Studies reporting health harms had higher odds of receiving negative critiques [OR = 0.29, 95% CI = (0.15-0.14)], as did studies minimising health benefits [OR = 0.21, 95% CI = (0.10-0.41)]. Algorithmic SA replicated these patterns, though the correlation with manual coding was modest [r = 0.20, 95% CI = (0.08-0.32)]. Studies with industry ties had higher odds of minimising alcohol-related harms [OR = 1.90, 95% CI = (1.04-3.50)], and those co-authored by ISFAR members had higher odds of reporting a J-shaped relationship between alcohol use and health [OR = 2.52, 95% CI = (1.00-6.48)]. No association was found between ISFAR sentiment and study quality as independently assessed by AMSTAR-2 and ROBIS (BF<sub>01</sub> = 6.13-6.21).</p><p><strong>Conclusion: </strong>Critiques from The International Scientific Forum on Alcohol Research (ISFAR) consistently promote alcohol's purported health benefits while minimising evidence of harm, regardless of study quality. These patterns provide a valuable resource for industry actors to shape public perception, downplay risk and influence policy-using strategies that closely resemble those historically employed by the tobacco industry.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/add.70132","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: The International Scientific Forum on Alcohol Research (ISFAR), many of whose members are linked to the alcohol industry, has published over 280 critiques on alcohol and health research. This study investigated whether ISFAR critiques favour studies reporting alcohol's health benefits while being more critical of those identifying harms. We also examined whether industry-funded studies are more likely to report benefits, and whether ISFAR's critiques reflect the methodological rigor of the studies they assess.

Methods: We analysed 268 ISFAR critiques published between April 2010 and January 2024, manually coding each underlying study for its content (whether the original study reported alcohol-related health benefits or harms) and each critique for its tone (positive or negative). Sentiment analysis (SA) algorithms were applied to critique summaries to assess tone using automated methods. Study authors were examined for prior receipt of alcohol industry funding. AMSTAR-2 and ROBIS tools evaluated risk of bias in 36 systematic reviews and meta-analyses favoured (n = 24) or criticised (n = 12) by ISFAR.

Results: Studies reporting health benefits had higher odds of receiving positive reviews from ISFAR [odds ratio (OR) = 6.50, 95% confidence interval (95% CI) = (3.62-12.00)], as did studies minimising alcohol harms [OR = 2.47, 95% CI = (1.40-4.45)]. Studies reporting health harms had higher odds of receiving negative critiques [OR = 0.29, 95% CI = (0.15-0.14)], as did studies minimising health benefits [OR = 0.21, 95% CI = (0.10-0.41)]. Algorithmic SA replicated these patterns, though the correlation with manual coding was modest [r = 0.20, 95% CI = (0.08-0.32)]. Studies with industry ties had higher odds of minimising alcohol-related harms [OR = 1.90, 95% CI = (1.04-3.50)], and those co-authored by ISFAR members had higher odds of reporting a J-shaped relationship between alcohol use and health [OR = 2.52, 95% CI = (1.00-6.48)]. No association was found between ISFAR sentiment and study quality as independently assessed by AMSTAR-2 and ROBIS (BF01 = 6.13-6.21).

Conclusion: Critiques from The International Scientific Forum on Alcohol Research (ISFAR) consistently promote alcohol's purported health benefits while minimising evidence of harm, regardless of study quality. These patterns provide a valuable resource for industry actors to shape public perception, downplay risk and influence policy-using strategies that closely resemble those historically employed by the tobacco industry.

国际酒精研究科学论坛(ISFAR)批评酒精研究:促进健康益处,淡化危害。
背景和目的:国际酒精研究科学论坛(ISFAR),其许多成员与酒精行业有联系,发表了280多篇关于酒精和健康研究的评论。这项研究调查了ISFAR的批评者是否更倾向于报告酒精对健康有益的研究,而对那些确定危害的研究持批评态度。我们还检查了行业资助的研究是否更有可能报告益处,以及ISFAR的批评是否反映了他们评估的研究方法的严谨性。方法:我们分析了2010年4月至2024年1月间发表的268篇ISFAR评论,对每一项潜在研究的内容(原始研究是否报告了与酒精相关的健康益处或危害)和每一项评论的语气(积极或消极)进行了手工编码。情感分析(SA)算法应用于评论摘要,使用自动化方法评估语气。对研究作者进行了检查,看他们是否事先接受了酒精行业的资助。AMSTAR-2和ROBIS工具评估了36篇系统综述和荟萃分析的偏倚风险,这些综述和荟萃分析被ISFAR支持(n = 24)或批评(n = 12)。结果:报告健康益处的研究获得ISFAR正面评价的几率更高[比值比(OR) = 6.50, 95%可信区间(95% CI) =(3.62-12.00)],最小化酒精危害的研究也是如此[OR = 2.47, 95% CI =(1.40-4.45)]。报告健康危害的研究收到负面评论的几率更高[OR = 0.29, 95% CI =(0.15-0.14)],最小化健康益处的研究也是如此[OR = 0.21, 95% CI =(0.10-0.41)]。算法SA复制了这些模式,尽管与手工编码的相关性不大[r = 0.20, 95% CI =(0.08-0.32)]。有行业联系的研究更有可能将酒精相关危害降至最低[OR = 1.90, 95% CI =(1.04-3.50)],由ISFAR成员共同撰写的研究更有可能报告酒精使用与健康之间的j型关系[OR = 2.52, 95% CI =(1.00-6.48)]。通过AMSTAR-2和ROBIS独立评估,未发现ISFAR情绪与研究质量之间存在关联(BF01 = 6.13-6.21)。结论:无论研究质量如何,国际酒精研究科学论坛(ISFAR)的评论一直在宣扬酒精对健康的益处,同时将危害的证据降至最低。这些模式为行业行为者提供了宝贵的资源,以塑造公众观念、淡化风险和影响政策——使用与烟草业历史上采用的策略非常相似的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Addiction
Addiction 医学-精神病学
CiteScore
10.80
自引率
6.70%
发文量
319
审稿时长
3 months
期刊介绍: Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信